7210 Wareham Drive, Tampa, FL 33647
Sept. 13, 2023 On August 8, Lilly reported that its second-quarter income jumped 85% from the same period a year ago, driven in large part by Mounjaro, which generated $979.7 million in sales for the quarter, compared to $16 million in the year-ago period and $569 million in the first quarter of this year. In […]
Obesity Drug Sales Continue To Soar Read More »
August 20, 2023 Boehringer Ingelheim could soon stake a claim in the lucrative obesity treatment market after the pharma company said it has advanced a candidate into three Phase III trials following promising data. Servodutide, the company’s glucagon/glucagon-like peptide 1 (GLP-1) receptor dual agonist co-developed with Zeland Pharma, demonstrated up to 19% weight loss after
More Obesity Drugs in the Pipeline – Boehringer Ingelheim Read More »
Aug. 8, 2023 Second quarter 2023 revenue decreased 34.7% to $296.2 million from $453.3 million for the second quarter of 2022, primarily driven by a decrease in the number of active earning OPTAVIA Coaches and the decline in the productivity per active earning OPTAVIA Coach. The average revenue per active earning OPTAVIA Coach was $5,578, compared to $6,667 for the second quarter last year, a
Medifast Reports Q2 Results Read More »
Aug. 5, 2023 WW reported its second quarter results yesterday. End of Period Subscribers of 4.1 million Revenues of $226.8 million Operating Income of $26.3 million; excluding the net impact of restructuring charges and acquisition transaction costs, adjusted operating income of $33.9 million Full Year Fiscal 2023 Guidance: Revenues are expected to be in the
Weight Watchers Reports 2nd Quarter 2023 Results Read More »
July 6, 2023 Nutrisystem’s parent company Wellful is reviving the brand this fall in a “convenient direct-to-consumer delivery model,” the company announced Wednesday. Jenny Craig went belly up in May after more than 40 years in business because of growing competition from other diets and the demand for weight loss drugs like Ozempic and Wegovy.
Jenny Craig Gets New Life, Online Read More »
June 5, 2023 There is no doubt that the new obesity drugs (Wegovy, Ozempic) are hot and in high demand, but there is a disturbing new trend developing. Since the brand name drugs often cost $1,000 to $1,300 per month and are not covered by insurance, people are looking for cheaper alternatives. That’s where compounding
Semaglutide Gold Rush Is On, Compounding Pharmacies Read More »
May 1, 2023 According to management: “We’re pleased to see revenue and operating income both ahead of expectations in the quarter, as we continue to adjust to the changing dynamics of the business environment,” said Dan Chard, Medifast’s Chairman & Chief Executive Officer. “Sustainable long-term growth is at the core of our focus, and we are
Medifast Reports 1st Quarter Results Read More »
May 8, 2023 It’s official, Jenny Craig has closed its doors, and will not be transitioning to an e-commerce model, as it had indicated last week. Operations in Australia, however, will remain open. Last week, Jenny Craig had alerted employees to potential mass layoffs as it begins “winding down physical operations” and hunts for a
Jenny Craig Out of Business Read More »
April 25, 2023 In case you haven’t noticed, literally hundreds of new market research firms have emerged from India in the last 5-10 years, usually headquartered in Pune. Their websites look legit and professional, and they claim to be located in the United States. But, they are usually a one-person operation. Many of these companies
Beware Fake Weight Loss Research From India Read More »
April 19, 2023 We obtained some information regarding Noom’s participation in the medical weight loss arena. “…Noom Clinical is offered to adults (18+) that are over BMI 30 or, BMI 27 and above with obesity-related conditions. Individual eligibility for specific options is determined by our trained clinicians and overseen by our Chief of Medicine. With
Noom Is Testing Weight Loss Drugs Read More »